Cargando…
Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
Synthetic lethality is a lethal phenomenon in which the occurrence of a single genetic event is tolerable for cell survival, whereas the co-occurrence of multiple genetic events results in cell death. The main obstacle for synthetic lethality lies in the tumor biology heterogeneity and complexity, t...
Autores principales: | Topatana, Win, Juengpanich, Sarun, Li, Shijie, Cao, Jiasheng, Hu, Jiahao, Lee, Jiyoung, Suliyanto, Kenneth, Ma, Diana, Zhang, Bin, Chen, Mingyu, Cai, Xiujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470446/ https://www.ncbi.nlm.nih.gov/pubmed/32883316 http://dx.doi.org/10.1186/s13045-020-00956-5 |
Ejemplares similares
-
Development of synthetic lethality in cancer: molecular and cellular classification
por: Li, Shijie, et al.
Publicado: (2020) -
Targeting mutant p53 for cancer therapy: direct and indirect strategies
por: Hu, Jiahao, et al.
Publicado: (2021) -
Comparison of Outcomes After Primary Laparoscopic Versus Open Approach for T1b/T2 Gallbladder Cancer
por: Cao, Jiasheng, et al.
Publicado: (2021) -
Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After Surgery
por: Chen, Mingyu, et al.
Publicado: (2021) -
Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth
por: Hu, Jiahao, et al.
Publicado: (2022)